This study investigated the effect of hydroalcoholic extract of Nigella sativa (N. sativa) and its active component, thymoquinone (TQ) on hypertension induced by angiotensin II (AngII), the main product of renin–angiotensin system (RAS).
Seven animal groups (n=7 for each group) were used as follows: (1) control, (2) AngII (300 ng/kg), (3) AngII+losartan (Los; 10 mg/kg), (4) TQ (40 mg/kg)+AngII, and (5–7) three doses of N. sativa (200, 400, and 600 mg/kg)+AngII. Los and AngII were injected intravenously; TQ and extracts were injected intraperitoneally. In TQ and N. sativa-treated groups, 30 min after injection of the extract and TQ, AngII was injected. Cardiovascular parameters were recorded by power lab system after cannulation of femoral artery. The maximum changes (∆) of systolic blood pressure (SBP), mean arterial pressure (MAP), and heart rate (HR) were calculated and used for statistical analysis.
AngII significantly increased maximal ∆SBP, ∆MAP, and ∆HR compared with the control (p<0.001), and these effects significantly were blunted by Los. TQ and two higher doses (400 and 600 mg/kg) of N. sativa significantly could antagonize effect of AngII on ∆SBP, ∆MAP (p<0.05 to p<0.001). AngII-induced changes of HR are also significantly decreased by TQ and dose 600 mg/kg of extract (p<0.01 and p<0.05, respectively).
The N. sativa and its component TQ have the beneficial effect on hypertension probably due to attenuation cardiovascular effects of AngII.
The authors would like to thank the Vice Presidency of Research Center of Mashhad University of Medical Sciences for their financial support.
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
1. Xie Y, Zhang W. Antihypertensive activity of Rosa rugosa Thunb. flowers: angiotensin I converting enzyme inhibitor. J Ethnopharmacol 2012;144:562–6.10.1016/j.jep.2012.09.038Search in Google Scholar PubMed
3. Program NHBPE. The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. 2004.Search in Google Scholar
4. Touyz RM, Schiffrin EL. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol Rev 2000;52:639–72.Search in Google Scholar PubMed
5. Zimmerman MC, Lazartigues E, Sharma RV, Davisson RL. Hypertension caused by angiotensin II infusion involves increased superoxide production in the central nervous system. Circ Res 2004;95:210–6.10.1161/01.RES.0000135483.12297.e4Search in Google Scholar PubMed
6. Kaleem M, Kirmani D, Asif M, Ahmed Q, Bano B. Biochemical effects of Nigella sativa L seeds in diabetic rats. Indian J Exp Biol 2006;2006:745–8.Search in Google Scholar
7. Mohebbati R, Abbsnezhad A, Khajavi Rad A, Mousavi SM, Haghshenas M. Effect of hydroalcholic extract of Nigella sativa on doxorubicin-induced functional damage of kidney in rats. Horizon Med Sci 2016;22:13–20.10.18869/acadpub.hms.22.1.13Search in Google Scholar
8. Ahmad A, Husain A, Mujeeb M, Khan SA, Najmi AK, Siddique NA, et al. A review on therapeutic potential of Nigella sativa: a miracle herb. Asian Pacific J Trop Biomed 2013;3:337–52.10.1016/S2221-1691(13)60075-1Search in Google Scholar
11. Gilani A, Aziz N, Khurram I, Chaudhary K, Iqbal A. Bronchodilator, spasmolytic and calcium antagonist activities of Nigella sativa seeds (Kalonji): a traditional herbal product with multiple medicinal uses. J Pakistan Med Assoc 2001;51:115–20.Search in Google Scholar
12. Razavi B, Hosseinzadeh H. A review of the effects of Nigella sativa L. and its constituent, thymoquinone, in metabolic syndrome. J Endocrinol Invest 2014;37:1031–40.10.1007/s40618-014-0150-1Search in Google Scholar PubMed
13. Shabana A, El-Menyar A, Asim M, Al-Azzeh H, Al Thani H. Cardiovascular benefits of black cumin (Nigella sativa). Cardiovasc Toxicol 2013;13:9–21.10.1007/s12012-012-9181-zSearch in Google Scholar PubMed
14. Jaarin K, Foong WD, Yeoh MH, Kamarul ZY, Qodriyah HM, Azman A, et al. Mechanisms of the antihypertensive effects of Nigella sativa oil in L-NAME-induced hypertensive rats. Clinics 2015;70:751–7.10.6061/clinics/2015(11)07Search in Google Scholar PubMed
15. Dehkordi FR, Kamkhah AF. Antihypertensive effect of Nigella sativa seed extract in patients with mild hypertension. Fundam Clin Pharmacol 2008;22:447–52.10.1111/j.1472-8206.2008.00607.xSearch in Google Scholar PubMed
16. Boskabady M, Shafei M, Parsaee H. Effects of aqueous and macerated extracts from Nigella sativa on guinea pig isolated heart activity. Die Pharmazie An Int J Pharm Sci 2005;60:943–8.Search in Google Scholar
17. Khattab MM, Nagi MN. Thymoquinone supplementation attenuates hypertension and renal damage in nitric oxide deficient hypertensive rats. Phytother Res 2007;21:410–4.10.1002/ptr.2083Search in Google Scholar PubMed
18. Fallah Huseini H, Amini M, Mohtashami R, Ghamarchehre M, Sadeqhi Z, Kianbakht S, et al. Blood pressure lowering effect of Nigella sativa L. Seed oil in healthy volunteers: a randomized, double-blind, placebo-controlled clinical trial. Phytother Res 2013;27:1849–53.10.1002/ptr.4944Search in Google Scholar PubMed
19. Mohebbati R, Shafei MN, Beheshti F, Soukhtanloo M, Roshan NM, Anaeigoudari A, et al. Mixed hydroalcoholic extracts of Nigella sativa and Curcuma longa improves adriamycin-induced renal injury in rat. Saudi J Kidney Dis Transpl 2017;28:1270.10.4103/1319-2442.220880Search in Google Scholar PubMed
20. Nasimi A, Shafei M, Alaei H. Glutamate injection into the cuneiform nucleus in rat, produces correlated single unit activities in the Kolliker-Fuse nucleus and cardiovascular responses. Neuroscience 2012;223:439–46.10.1016/j.neuroscience.2012.07.041Search in Google Scholar PubMed
21. Shafei MN, Niazmand S, Hosseini M, Daloee MH. Pharmacological study of cholinergic system on cardiovascular regulation in the cuneiform nucleus of rat. Neurosci Let 2013;549:12–7.10.1016/j.neulet.2013.05.046Search in Google Scholar PubMed
22. Leong X-F, Rais Mustafa M, Jaarin K. Nigella sativa and its protective role in oxidative stress and hypertension. Evid Based Compl Alternat Med 2013;2013:1–9.Search in Google Scholar
23. Mehta PK, Griendling KK. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol 2007;292:C82–97.10.1152/ajpcell.00287.2006Search in Google Scholar PubMed
24. Veerasingham SJ, Raizada MK. Brain renin–angiotensin system dysfunction in hypertension: recent advances and perspectives. Br J Pharmacol 2003;139:191–202.10.1038/sj.bjp.0705262Search in Google Scholar PubMed PubMed Central
25. Muñoz-Durango N, Fuentes CA, Castillo AE, González-Gómez LM, Vecchiola A, Fardella CE, et al. Role of the renin-angiotensin-aldosterone system beyond blood pressure regulation: molecular and cellular mechanisms involved in end-organ damage during arterial hypertension. Int J Mol Sci 2016;17:797.10.3390/ijms17070797Search in Google Scholar PubMed PubMed Central
27. Al-Majed AA, Daba MH, Asiri YA, Al-Shabanah OA, Mostafa AA, El-Kashef HA. Thymoquinone-induced relaxation of guinea-pig isolated trachea. Res Commun Mol Pathol Pharmacol 2000;110:333–45.Search in Google Scholar
28. Ottaviani JI, Actis-Goretta L, Villordo JJ, Fraga CG. Procyanidin structure defines the extent and specificity of angiotensin I converting enzyme inhibition. Biochime 2006;88:359–65.10.1016/j.biochi.2005.10.001Search in Google Scholar
29. Hansson L, Lindholm LH, Niskanen L, Lanke J, Hedner T, Niklason A, et al. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial. Lancet 1999;353:611–6.10.1016/S0140-6736(98)05012-0Search in Google Scholar PubMed
30. Laursen JB, Rajagopalan S, Galis Z, Tarpey M, Freeman BA, Harrison DG. Role of superoxide in angiotensin II–induced but not catecholamine-induced hypertension. Circulation 1997;95:588–93.10.1161/01.CIR.95.3.588Search in Google Scholar PubMed
31. Rajagopalan S, Kurz S, Münzel T, Tarpey M, Freeman BA, Griendling KK, et al. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 1996;97:1916.10.1172/JCI118623Search in Google Scholar PubMed PubMed Central
32. Reid I. Interactions between ANG II, sympathetic nervous system, and baroreceptor reflexes in regulation of blood pressure. Am J Physiol-Endocrinol Metab 1992;262:E763–78.10.1152/ajpendo.1992.262.6.E763Search in Google Scholar PubMed
33. Dampney R, Fontes M, Hirooka Y, Horiuchi J, Potts P, Tagawa T. Role of angiotensin II receptors in the regulation of vasomotor neurons in the ventrolateral medulla. Clin Exp Pharmacol Physiol 2002;29:467–72.10.1046/j.1440-1681.2002.03658.xSearch in Google Scholar PubMed
©2019 Walter de Gruyter GmbH, Berlin/Boston